Your CIMT Results
Are In. Here's What They Mean.
Your CIMT is done. Fill out the short form below and you'll get access to a free narrated walkthrough that explains what your results actually mean and what to do next.
See What My Results MeanFill Out the Form
and We'll Take It From There.
Submit the short form and you'll go straight to your free results walkthrough. A BaleDoneen arterial health expert explains your CIMT report from top to bottom in plain language.
Your information is never sold or shared.
Here's What You'll Learn
In Your Free Review.
Fill out the form below and you'll get access to a free narrated walkthrough of your CIMT report. A BaleDoneen arterial health expert who has spent over 15 years working alongside the founders of the Method walks through every section in plain language.
I spent 30 years fighting fires. In 2018, I needed three stents. In 2023, after a normal stress test, I had a heart attack and needed three more. Six stents and I still did not feel protected. The BaleDoneen Method changed that. They focused on the root cause, not just the symptoms. I have had a heart attack, and I am not having another.
I finally feel like I have answers, not just wait and see. There is a way that we can actually prevent heart disease and stroke before it happens.
I know for sure I am protected, not just hoping for the best. The BaleDoneen Method has enabled me to have my health and my future back.
These doctors are doing God's work. Instead of treating the disease, they are focused on preventing the disease in the first place. Highly recommend!
Questions We
Hear All the Time.
Everything you need to know before accessing your results review.
The CIMT screening provides the imaging, the measurements, and the report. The BaleDoneen Method is the clinical approach that uses your CIMT results as a starting point to identify the root causes of arterial disease and build a personalized prevention plan. Think of the CIMT as the diagnostic tool and the BaleDoneen Method as what you do with what you find.
A normal CIMT result is encouraging, but it doesn't always mean the absence of arterial disease. The carotid artery is often one of the last places disease shows up. If you have risk factors like elevated cholesterol, Lp(a), family history of heart disease, poor dental health, sleep issues, or autoimmune conditions, disease may already be present elsewhere. The free results review covers this in detail and explains when and why further investigation makes sense.
The review is a narrated video walkthrough of your CIMT report created by a BaleDoneen arterial health expert with over 15 years working alongside the founders of the BaleDoneen Method. She walks through every section of the report — plaque, IMT values, arterial age, early event risk — in plain language. She also explains the science behind the BaleDoneen Method and covers the Telemed Program for those who want to take the next step. No pressure, just information.
No insurance needed. The program is cash-pay with a flat fee: $920 for your provider consultation and personalized assessment, and $405 for your lab panel, $1,325 total. Most of the testing involved isn't covered by standard insurance anyway, so patients generally find this straightforward.
You get labs done at a location near you — walk-in, most sites don't require an appointment. Then you meet virtually with a BaleDoneen-trained provider who goes through your labs, your CIMT results, and your health history to build a plan around what's actually driving the problem for you. Everything except the labs is done from home.
Yes. Clinical studies on patients using the BaleDoneen Method have shown measurable reduction in artery wall thickness and 100% plaque stabilization — dangerous soft plaque converting to stable, low-risk plaque. Patients who had already had heart attacks and strokes have stabilized and reversed their disease. When you find the actual root cause and address it, the body responds.
It lets us make sure a BaleDoneen team member can follow up if you have questions after watching. Your information is never sold or shared, and it takes under a minute.
Ready to Go Deeper?
Here's What's Next.
If the results review raises questions and you want to go further, here's what the next step actually involves.
Advanced Testing + Personalized Plan
Enrollment includes a comprehensive lab panel, genetic testing, and a virtual consultation with a BaleDoneen-trained provider who reviews everything and puts together a plan specific to you. Labs are the only thing done in person.
Stay Protected Year After Year
After your initial enrollment, ongoing care keeps things moving. Your provider checks in on your progress, adjusts your plan as needed, and stays in touch with your existing care team.
Your Scan Is Done.
Now Find Out What It Means.
Over 10,000 patients have used the BaleDoneen Method to find the root cause of their arterial disease before something worse happened. Your results are worth understanding.
See What My Results MeanThe Carotid Intima-Media Thickness (CIMT) scan and any related measurements, findings, or interpretations are provided for informational and educational purposes only. They are not intended to diagnose, treat, cure, or prevent any disease, nor should they be used as a substitute for professional medical advice, diagnosis, or treatment.
CIMT results represent a single assessment of arterial wall thickness and plaque burden at the time of imaging and must be interpreted in the context of the patient's complete medical history, risk factors, symptoms, laboratory data, and other diagnostic studies. CIMT findings alone cannot determine cardiovascular risk or clinical outcomes.
Clinical decisions should only be made by a qualified healthcare professional. Patients should not make changes to medications, lifestyle, or treatment plans based solely on CIMT results without consulting their physician or other licensed healthcare provider.
If you have symptoms suggestive of cardiovascular disease or concerns regarding your health, seek prompt medical evaluation from a qualified professional.









